But here's what I don't understand -- why would the FDA
But here's what I don't understand -- why would the FDA have allowed Leronlimab to be used for 30 or so EIND critically ill patients, if not to hopefully save lives?
_____________
Because the FDA, just any other state agency, must first and foremost cover their behinds. It's a part of the game. Let's suppose the "American public" is something that really exist and even can wage a powerful protest through "free press" which would make TPTB to investigate the FDA's games with CYDY. The agency then will have the irrefutable evidence of its good will, nay, its eagerness to go an extra mile for the sake of the American people. They allowed Leron as many COVID-19 EINDs as were requested. They speedily approved its two clinical studies for COVID-19. They approved a basket cancer trial and gave other similar goodies to NP. They had approved Leron for the HIV combo! And if all this evidence is still not enough for the American public and FBI, listen to each and every public appearance of Mr. Pourhassan in which he showers our agency with endless praises! Of course, none of the above matters at all! For the FDA, as any other state agency, has up its sleeve the endless number of tricks not to allow the commercialization of any drug that they for whatever reason don't want to succeed. On my short memory of following CYDY they used only one of those tricks when out of the blue they told NP to change the clinical part of BLA just "nine days" before it was ready to be submitted. And this little trick alone has cost us already 4 months and counting. Yep, it will be a lengthy uphill struggle with by no means certain results.
1
CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
When Hotels Stand Up for Heroes Every now and then, you stumble upon a company doing something genuinely good, and Staypineapple's effort this November is one of those rare gems. In honor of Veterans Day, they're opening their checkbook to sling some real support to our nation’s vets and retired first responders. Their chosen cause? The American Humane Society's...
Continue Reading
In a world where medical advancements keep shifting gears, BRIJ Medical just pulled a fast one by closing a $5 million financing round—outpacing their original $3 million target. What drove this sudden increase? Well, it's simple. Their existing investors spotted an opportunity too ripe to pass up, proving yet again, money talks when confidence backs it up. Expanding...
Continue Reading
The Quiet Revolution: Linux Takes Center Stage Linux, once the underdog of operating systems, is gaining significant traction in the world of AI development. It's not just a nerd's sandbox anymore; it's rapidly becoming the go-to platform for cutting-edge AI innovation. Now, more enterprise IT departments are facing the choice of keeping up with Linux's popularity—or...
Continue Reading
The Big Ten-Cent Copper Push If you’ve been sniffing around the European mining scene, ACG Metals’ latest move might just kick the tracks out from under you. They’re snapping up Blue Moon Norway for a cool $220 million in stock, and folks, that’s no chump change. This ain’t just some idle acquisition either; it’s a strategic stab at swelling their copper...
Continue Reading
When Makeup Meets Pajamas: The Perfect Storm Picture this: a makeup brand and a lifestyle label dreaming up a collaboration that sends consumers into a full-blown frenzy. In a whirlwind that lasted just 60 seconds, tarte's latest partnership with Roller Rabbit blazed through stock, cementing its place as a record-breaking phenomenon. Maureen Kelly, tarte’s intrepid CEO,...
Continue Reading
Innovation Steals the Show in Guangzhou In a world where tech evolution rarely takes a breather, the 140th Canton Fair's Intelligent Healthcare Zone is like a breath of fresh air. Picture it: a whole arena pulsing with futuristic healthcare gizmos from October 31 to November 4, 2026—it's as if tomorrow swung by for a sneak peek. The event brings together everything from...
Continue Reading
Election Day Drama: Metals Market Jitters You'd think with all the election day hoopla, the metal futures would hold steady. But here we are, seeing gold, silver, and copper futures retracting like a scared turtle. Monday, they all roared upward. Tuesday morning, they're backpedaling. December gold futures took a hit, dropping 0.78% to land at $3,938.50 an ounce. Silver...
Continue Reading
Florida Properties: The Buried Risk in Flood Zones If you’re dreaming of palm trees and sandy beaches, don't let flood zones turn that dream into a nightmare. It’s not all sunshine and rainbows when it comes to buying real estate in Florida, as it turns out—flood zones are lurking, and the devil's in the details. Understanding FEMA Flood Maps First off, these FEMA...
Continue Reading
Industrial Automation Surge: A New Era Dawns There's no denying it, folks: the gears are turning at a breakneck pace in the industrial automation world. We've got our eyes set on a staggering climb from $266.7 billion in 2026 to a jaw-dropping $410.3 billion by 2031. That's a 9% annual growth rate that's got investors salivating. Robotics and AI: Leading the Charge Look...
Continue Reading
Another Distribution Hike: 12.5% Bump in Q3 Man, MPLX is at it again, boosting that quarterly distribution by a hefty 12.5%. That's three years running now, marking it up to $4.84 per unit on an annualized basis. In an industry where reliability sometimes feels like a relic, this kind of consistency is a sweet serenade to any income-focused investor's ears. "MPLX is...
Continue Reading
Top 5 Most Recently Viewed Articles
Mythos AI Achieves Milestone in Autonomous Navigation In a groundbreaking achievement, Mythos AI has successfully surpassed 11,000 miles of fully autonomous navigation, marking a significant advancement in shipping technology. The company's AI-driven navigation system not only exceeds military-grade capabilities in safety and operational efficiency but also sets a new...
Continue Reading
Jungbunzlauer Introduces Magnesium Bisglycinate Jungbunzlauer, a prominent name in the realm of sustainable ingredients, is pleased to announce a groundbreaking addition to its mineral portfolio. The company will be featuring its newly developed fully-reacted magnesium bisglycinate at SupplySide Global 2025 in Las Vegas. This debut is a testament to Jungbunzlauer’s...
Continue Reading
Broadridge Enhances Platform for Investment Managers Global fintech leader Broadridge Financial Solutions, Inc. (NYSE: BR) has introduced significant upgrades to its multi-asset portfolio and trade order management platform. These enhancements, which include new general ledger functionalities and a redesigned user interface (UI), are designed to improve operational...
Continue Reading
Integral Metals Completes Debt Repayment CALGARY, Alberta — Integral Metals Corp. (CSE: INTG), an innovative exploration stage company focused on critical minerals, has successfully repaid its secured convertible debt in cash. This strategic move not only showcases the company’s commitment to its financial obligations but also enhances its efforts in exploring and...
Continue Reading
IPS Newcastle Celebrates Award Recognition IPS Newcastle has proudly received the prestigious Association of Electrical & Mechanical Trades (AEMT) Service Centre of the Year Award, affirming its position as a leader in the industry. This accolade highlights the remarkable operational excellence the team maintains and is one of only eight awards presented during the annual...
Continue Reading